1. Practice

The antihistamine pairing people are quietly asking about.

Here is a question I get more than you would expect: "My doctor mentioned taking Claritin and Pepcid together for my stomach. Is that crazy?"

It is not crazy. It is also not a cure. Let me walk through why the idea exists, because the reasoning is more interesting than the pills.

Histamine is not just an allergy molecule. Most people meet it through hay fever and hives, but histamine is a signaling chemical the body uses in a lot of places, and one of the busiest is the gut. Your intestinal wall is packed with mast cells, which are immune cells that store histamine and other mediators and release them when triggered. When mast cells in the gut fire, they can irritate the dense web of nerves in the intestinal wall, sometimes called the enteric nervous system, which is why people describe it as a "second brain." That nerve network talks constantly to the actual brain. Turn up the volume on the gut nerves and the brain starts reading normal digestion as pain, urgency, or nausea. That amplified signaling is what clinicians mean by visceral hypersensitivity, and when the whole pain-processing system gets turned up over time, we call it central sensitization.

This matters for disorders of gut-brain interaction, or DGBI. That is the current term (not "functional GI disorders") for conditions like irritable bowel syndrome (IBS), cyclic vomiting syndrome, and cannabinoid hyperemesis syndrome (CHS). What ties these together is not a broken organ you can see on a scan (a “hardware problem), but a miscommunication between gut and brain (a “software problem). And histamine and mast cells appear to be part of the wiring in at least a subset of patients.

So where do the two drugs come in? Histamine acts on different receptors, which are the docking stations on cells. The H1 receptor is the one classic allergy pills target (loratadine, brand name Claritin, is a common over-the-counter, or OTC, H1 blocker). The H2 receptor is the one heartburn drugs target (famotidine, brand name Pepcid, is a common OTC H2 blocker). Both receptor types show up in the gut and in pain and nausea pathways. The logic of blocking both at once is simple: if histamine is contributing to the problem through more than one door, close more than one door. That is why some clinicians discuss combining an H1 and an H2 blocker in patients with IBS, cyclic vomiting, CHS, or prominent visceral hypersensitivity, often the ones whose symptoms have an allergic or histamine-flavored quality (flushing, itch, food reactivity, hives alongside the gut trouble).

The agents involved are ordinary and familiar. Loratadine and famotidine are both sold over the counter at standard doses most people have taken at some point for allergies or heartburn. That accessibility is part of why the combination gets talked about at all.

Full dislocure, though…this is largely mechanistic reasoning plus small studies and clinical experience, not large randomized controlled trials. The mast-cell-and-histamine story in IBS is real and supported by tissue studies, and mast-cell-directed treatments (including antihistamines and mast-cell stabilizers) have shown promise in small trials for subsets of patients. But "biologically plausible and helpful for some people in small studies" is a very different claim from "proven treatment for everyone with these conditions." It is not a guaranteed fix for IBS, but it is a reasonable, safe, low-cost thing to consider, especially if your picture has that histamine flavor.

2. Publication

One paper worth reading, in three sentences.

Work from the Leuven group in Belgium (Guy Boeckxstaens and colleagues) has been central to showing that mast cells and histamine signaling drive abdominal pain and visceral hypersensitivity in IBS, not just as a bystander but as part of the mechanism. Their line of research includes evidence that histamine acting through gut sensory nerves sensitizes them, and that blocking the H1 receptor can reduce that sensitization and improve symptoms in a subset of IBS patients. If you read one thing to understand why the antihistamine idea has legs, look at this group's work on histamine, TRPV1, and visceral pain in IBS (their other studies are widely cited and easy to find in PubMed under Boeckxstaens IBS histamine).

3. Product

This week's pick: a plain, well-built symptom journal. Unsponsored, obviously.

If you are going to have the antihistamine conversation (or any conversation) with your doctor, the single most useful thing you can bring is data. Not a vague "my stomach's been bad." A dated log of symptoms, foods, cannabis use if relevant, sleep, stress, and what you took and whether it helped.

My editorial pick is any simple, undated daily symptom and food journal, the kind sold as a small softcover notebook with a line for date, meals, symptoms, and severity. Brands matter less than the format. Look for one page per day, a 1-to-10 severity scale, and a notes line. The "undated" ones are better because you can skip days without guilt. A five-dollar notebook you actually fill in beats a fancy app you abandon in a week. Pattern recognition is where DGBI treatment lives, and you cannot see a pattern you never wrote down.

4. Person

One person worth following in this space.

Guy Boeckxstaens, MD, PhD, a gastroenterologist and researcher at KU Leuven. If the mast-cell and histamine thread in this issue interested you, he is one of the people who built the scientific case for it. His group's work is the reason "histamine and visceral hypersensitivity" is a serious research area and not a fringe idea. You will find him through his publication list on PubMed. Not flashy on social media, which is fine, the work speaks.

That's the four. See you next week.

Rick

From BellyMD

I build MGB+, a small supplement line for gut-brain support: Clear, Cool, and Calm, each a magnesium and B-vitamin based formula meant to support the gut-brain axis as part of a broader routine. Structure-function support, not a treatment for any disease. If that is relevant to you, it lives at belly-md.com.

Not medical advice. This newsletter is for education and does not create a physician-patient relationship. Nothing here is a diagnosis or a prescription. Talk to your own physician before starting, stopping, or combining any medication or supplement, including over-the-counter ones.